A substantive amendment to this review was published on May 26th 2004.
The reviewers conclude: based on the best current available evidence, it would seem advisable for women to continue medication during pregnancy using monotherapy at the lowest dose required to achieve seizure control. Polytherapy would seem best avoided where possible. More population based studies adequately powered to examine the effects of in utero exposure to specific monotherapies which are used in everyday practice are required.
No comments:
Post a Comment